- Messages
- 171
- Location
- London
Does anyone know when and if there will be a followup study to try and replicate John Chia's work? I seem to remember Enlander mentioning something about this some time ago, but I'm not sure. Anyone?
I'm not aware of anything concrete at this point. A fellow patient reported that Dr. Chia told him the CDC had requested some of his samples for further study but I haven't seen anything further about that since.Does anyone know when and if there will be a followup study to try and replicate John Chia's work? I seem to remember Enlander mentioning something about this some time ago, but I'm not sure. Anyone?
It's on page 160:The IOM report mentions something about Chia and the enterovirus work. I think it said something like was unable to be replicated. Dont quote me but something like this was in there.
Enterovirus A few studies focused on the role of persistent enterovirus
infection in ME/CFS (Chia et al., 2010; Galbraith et al., 1995; Lane et al.,
2003). Chia and Chia (2008) showed that in a subset of ME/CFS patients
who reported significant gastrointestinal complaints, the prevalence of
enterovirus infection as demonstrated in stomach biopsy samples was significantly
higher compared with control subjects. Other investigators failed
to reproduce an increased incidence of enterovirus infection in ME/CFS
patients (Lindh et al., 1996).
One negative study on a total of 34 patients, not too convincing. They also used a number of methods of detection that are prone to error.
The failed study noted in the IOM report was from Sweden. He talks about it briefly in this paper:I have not actually looked at these failed US replication studies.
Several other studies have failed to demonstrate amplifiable enteroviral RNA in blood or in other tissue,24,25 although two recent papers again demonstrated the presence of enteroviral RNA in muscle biopsies of patients with CFS and not in the controls.26,27 The discrepancy between the various studies is not well explained, but could result from differences in specimen collection and RNA preservation, the time to processing of the biopsies or blood samples, the primers used, and the sensitivity of the assay.
The failed study noted in the IOM report was from Sweden. He talks about it briefly in this paper:
I looked at the papers done by the British investigators I found these to be really interesting. Unless they blatantly lied about their findings, I can't believe why these were denied in the first place.
...
If I quickly review some of the literature that the British investigators generated. This slide is important, because there was a 30 year old female that developed ME/CFS for about five years, and committed suicide. Before she died and was . . . the family gave doctors the chance to find the virus in the tissues.
So they were able to find enterovirus RNA in the muscles, heart, hypothalamus, and in the brainstem, and the RNA sequence shows about 83% homology to what we call Coxsackie B3. That is only one patient, published 1994. That has not been done again. But you don't get a chance like this very often. But this clearly shows the virus can go to the various areas where patients are complaining about symptoms.
The other study that needs to be quoted is this blinded control studies done by Clements, et al, and they were able to find enterovirus RNA in the CF patient's serum, about 41% and the control serum was only 2%.
Unfortunately our American investigators could not reproduce this finding. So basically this was left, in 1995, as probably a disease of the mind. And because of some the special comments made, but I'm not going to go over that issue right now.
Video Timecode: 12:31.
It turns out there is a CDC CFS conference call coming up on Monday, including a Q&A segment. I will submit a question regarding the status of this.Later in the year he told us that the CDC was going to look at his samples as well. He asked for permission to send my son's biopsy samples to the CDC and we agreed. The next time we saw him he said that the CDC had his samples, but was putting his project on hold as enterovirus D68 was becoming a more urgent problem.
It turns out there is a CDC CFS conference call coming up on Monday, including a Q&A segment. I will submit a question regarding the status of this.
Starting at time 14:30 in that talk is kind of what I was thinking about. What I was thinking of more was from this 2008 talk. At 12:44, he talks about the PCR test being difficult to get right.In the Invest in ME London 2010 ME/CFS Conference DVD Dr John Chia said this:
Again, from the above 2008 talk, at 9:07 I believe this is the American study that could not reproduce the findings. This was apparently from unpublished work by Stephen Straus and H. Robart. At 15:02 he talks about the difference between how Robart did it and how he did it.When Chia says in the quote above that "our American investigators could not reproduce this finding", I am not sure which papers he is referring to.
I believe this is true. For example, Dr. Chia said that echovirus 7 is completely unresponsive to oxymatrine. He's verified it in vitro.I don't know for sure, but I think this specific serotype information from ARUP Lab might be useful in terms of tailoring the antiviral treatment.
I believe the antibody tests are accurate. They are far from perfect, but they're a good place to start. They have a few problems:
I believe this is true. For example, Dr. Chia said that echovirus 7 is completely unresponsive to oxymatrine. He's verified it in vitro.